Explore the detailed record of transactions filed by FOEHR MATTHEW W, Président. Officer active across 2 companies, notably Ligand Pharmaceuticals INC. Aggregated, 14 filings have been published. Total volume traded: €492k. The latest transaction was filed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
FOEHR MATTHEW W serves as President and COO at Ligand Pharmaceuticals Inc and Viking Therapeutics, Inc. In this role, he is responsible for the strategic direction of the companies and managing operations. His leadership is essential in ensuring the growth and sustainability of the companies.